SYN-TECH Chem. & Pharm. Co., Ltd.
Taipei ExchangeTotal Valuation
SYN-TECH Chem. & Pharm. Co., Ltd. carries a market capitalization of 3.34B, placing it among publicly traded companies globally. Its enterprise value stands at 3.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.34B |
| Enterprise Value | 3.15B |
Share Statistics
SYN-TECH Chem. & Pharm. Co., Ltd. currently has 44.59M shares outstanding.
| Shares Outstanding | 44.59M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
SYN-TECH Chem. & Pharm. Co., Ltd. trades at a trailing price-to-earnings ratio of 12.96. The price-to-sales ratio is 3.02, and the price-to-book ratio stands at 3.35.
| PE Ratio | 12.96 |
| PS Ratio | 3.02 |
| PB Ratio | 3.35 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | 4.35 |
| P/OCF Ratio | 5.48 |
Enterprise Valuation
On an enterprise value basis, SYN-TECH Chem. & Pharm. Co., Ltd. trades at an EV/EBITDA multiple of 10.06 and an EV/FCF ratio of 3.52. The EV/Sales ratio of 2.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.06 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.45 |
| EV / EBITDA | 10.06 |
| EV / EBIT | 10.06 |
| EV / FCF | 3.52 |
Financial Position
SYN-TECH Chem. & Pharm. Co., Ltd. maintains a current ratio of 3.18, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.92, indicating elevated leverage, while an interest coverage ratio of 368.88 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.18 |
| Quick Ratio | 1.84 |
| Debt / Equity | 4.92 |
| Debt / EBITDA | 0.38 |
| Interest Coverage | 368.88 |
Financial Efficiency
SYN-TECH Chem. & Pharm. Co., Ltd. posts a return on equity of 26.18 and a return on invested capital of 9.72.
| Return on Equity (ROE) | 26.18 |
| Return on Assets (ROA) | 10.45 |
| Return on Invested Capital (ROIC) | 9.72 |
| Return on Capital Employed (ROCE) | 23.59 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.85 |
Taxes
Over the trailing twelve months, SYN-TECH Chem. & Pharm. Co., Ltd. has paid 74.66M in income taxes, reflecting an effective tax rate of 19.95.
| Income Tax | 74.66M |
| Effective Tax Rate | 19.95 |
Stock Price Statistics
SYN-TECH Chem. & Pharm. Co., Ltd.'s stock has declined approximately -9.63855% over the past 52 weeks. The 50-day moving average sits at 71.59, while the 200-day moving average is 73.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | -9.63855% |
| 50-Day Moving Average | 71.59 |
| 200-Day Moving Average | 73.18 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, SYN-TECH Chem. & Pharm. Co., Ltd. generated 1.29B in revenue and converted that into 299.66M in net income, yielding earnings per share of 6.70. EBITDA reached 312.81M, while operating income came in at 312.81M.
| Revenue | 1.29B |
| Gross Profit | 447.01M |
| Operating Income | 312.81M |
| Pretax Income | 374.32M |
| Net Income | 299.66M |
| EBITDA | 312.81M |
| EBIT | 312.81M |
| Earnings Per Share (EPS) | 6.70 |
Balance Sheet
SYN-TECH Chem. & Pharm. Co., Ltd. holds 856.16M in cash and equivalents against 118.77M in total debt, resulting in a net debt position of -796.49M. Total book value stands at 1.16B, with working capital of 1.01B providing operational flexibility.
| Cash & Cash Equivalents | 856.16M |
| Total Debt | 118.77M |
| Net Debt | -796.49M |
| Equity (Book Value) | 1.16B |
| Book Value Per Share | 25.93 |
| Working Capital | 1.01B |
Cash Flow
SYN-TECH Chem. & Pharm. Co., Ltd. produced 709.33M in operating cash flow over the past twelve months. After subtracting -183.58M in capital expenditures, free cash flow totaled 525.74M - equivalent to 11.76 per share.
| Operating Cash Flow | 709.33M |
| Capital Expenditures | -183.58M |
| Free Cash Flow | 525.74M |
| FCF Per Share | 11.76 |
Margins
SYN-TECH Chem. & Pharm. Co., Ltd. operates with a gross margin of 34.77, reflecting its pricing power and cost economics. The operating margin of 24.33 and net profit margin of 23.31 provide insight into operational efficiency.
| Gross Margin | 34.77 |
| Operating Margin | 24.33 |
| Pretax Margin | 29.12 |
| Profit Margin | 23.31 |
| EBITDA Margin | 24.33 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.19 |
| FCF Yield | 22.97 |
Stock Splits
SYN-TECH Chem. & Pharm. Co., Ltd.'s most recent stock split took place on November 16, 2021 with a 500:517 split ratio.
| Last Split Date | 11/16/2021 |
| Split Ratio | 500:517 |
Scores
SYN-TECH Chem. & Pharm. Co., Ltd. posts an Altman Z-Score of 5.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.89 |